Deep Dive: Market Access

Market Access

Rare diseases: the urgent need for health equity and acceler...

Rare diseases are complex, but the need is urgent. Alexion’s Eunice Alvazzi discusses the shared responsibility in achieving access to innovation in rare diseases

Market Access

Deep Dive: Market Access 2024

In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna

Market Access

12 questions with: Gerwin Winter

Gerwin Winter joined BeiGene in March 2021 as senior vice president, head of Europe.

Market Access

Trust takes time. But a data-driven digital healthcare syste...

The NHS needs to find a way to put privacy first to build trust with the public around its innovation plans, explains Nigel Jones, co-founder of the Privacy Compliance Hub.

Market Access

Addressing Europe’s plasma deficit

Across the European Union approximately 300,000 patients with chronic conditions, such as haemophilia and severe immune-deficiency, depend on plasma-derived medicines, which can only be man

Market Access